Stock listing
Frankfurt:BE50 CNS Pharmaceuticals, Inc. Aktie
German listing (Frankfurt) of CNS Pharmaceuticals, Inc. · home listing NASDAQ:CNSP
Follow CNS Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CNSP
$5.00 USD +0.23 (+4.8%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CNSP
- Day range
- $4.25 – $5.00 USDOct 30, 2026
- Volume
- 52,917 sharesOct 30, 2026
- Market cap
- $7.31M USDAt the close on Oct 30, 2026 · price × 1.46M shares outstanding
- 52-week range
- $1.90 – $10.54 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $47,173 USDMedian day 3,800 shares · 1 day with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CNSP · Home | $5.00 USD | +0.23 (+4.8%) | 52,917 | $4.60 | $5.00 | $4.25 | $4.77 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:CNSP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $5.00 | +0.23 | +4.8% | $4.60 | $5.00 | $4.25 | 52,917 | |
| $4.77 | +0.26 | +5.8% | $4.60 | $5.08 | $4.35 | 46,373 | |
| $4.51 | -0.57 | -11.2% | $4.30 | $5.37 | $4.30 | 61,129 | |
| $5.08 | +0.455 | +9.8% | $4.68 | $5.20 | $4.16 | 74,953 | |
| $4.625 | -0.345 | -6.9% | $4.53 | $4.625 | $4.525 | 2,083 | |
| $4.97 | +0.22 | +4.6% | $4.50 | $5.00 | $3.67 | 5,965 | |
| $4.75 | -0.075 | -1.6% | $4.75 | $4.95 | $3.98 | 10,000 | |
| $4.825 | -0.165 | -3.3% | $4.825 | $4.825 | $4.825 | 300 | |
| $4.99 | 0.00 | 0.0% | $4.99 | $4.99 | $4.99 | 0 | |
| $4.99 | +0.139 | +2.9% | $4.85 | $5.00 | $4.755 | 5,600 | |
| $4.851 | -0.326 | -6.3% | $4.98 | $5.00 | $4.65 | 13,400 | |
| $5.177 | -0.173 | -3.2% | $5.177 | $5.177 | $5.177 | 900 | |
| $5.35 | 0.00 | 0.0% | $5.35 | $5.35 | $5.35 | 655 | |
| $5.35 | +0.16 | +3.1% | $5.13 | $5.40 | $5.00 | 14,200 | |
| $5.19 | -0.16 | -3.0% | $5.34 | $5.40 | $5.03 | 6,200 | |
| $5.35 | 0.00 | 0.0% | $5.35 | $5.35 | $5.34 | 1,200 | |
| $5.35 | -0.08 | -1.5% | $5.36 | $5.36 | $5.35 | 1,800 | |
| $5.43 | +0.128 | +2.4% | $5.35 | $5.44 | $5.082 | 2,700 | |
| $5.302 | +0.002 | 0.0% | $5.40 | $5.45 | $5.302 | 6,200 | |
| $5.30 | -0.025 | -0.5% | $5.50 | $5.50 | $5.30 | 2,000 | |
| $5.325 | +0.085 | +1.6% | $5.23 | $5.40 | $5.11 | 10,900 | |
| $5.24 | -0.06 | -1.1% | $5.35 | $5.35 | $5.24 | 900 | |
| $5.30 | +0.393 | +8.0% | $5.25 | $5.475 | $4.93 | 8,000 | |
| $4.907 | -0.203 | -4.0% | $4.907 | $4.907 | $4.907 | 500 | |
| $5.11 | +0.179 | +3.6% | $4.982 | $5.11 | $4.97 | 2,400 | |
| $4.931 | -0.219 | -4.3% | $5.21 | $5.21 | $4.931 | 1,300 | |
| $5.15 | 0.00 | 0.0% | $5.15 | $5.15 | $5.15 | 1,800 | |
| $5.15 | -0.089 | -1.7% | $5.15 | $5.15 | $5.15 | 2,900 | |
| $5.239 | +0.02 | +0.4% | $5.245 | $5.245 | $5.00 | 2,700 | |
| $5.219 | +0.109 | +2.1% | $5.12 | $5.50 | $5.12 | 2,300 | |
| $5.11 | -0.01 | -0.2% | $5.12 | $5.12 | $5.06 | 4,400 | |
| $5.12 | -0.38 | -6.9% | $5.35 | $5.35 | $5.05 | 2,600 | |
| $5.50 | -0.20 | -3.5% | $5.54 | $5.54 | $5.50 | 3,900 | |
| $5.70 | 0.00 | 0.0% | $5.70 | $5.70 | $5.70 | 2,000 | |
| $5.70 | -0.14 | -2.4% | $5.70 | $5.70 | $5.70 | 1,000 | |
| $5.84 | +0.09 | +1.6% | $5.845 | $5.845 | $5.73 | 18,500 | |
| $5.75 | -0.03 | -0.5% | $5.79 | $5.79 | $5.75 | 1,600 | |
| $5.78 | -0.16 | -2.7% | $5.89 | $5.94 | $5.76 | 2,700 | |
| $5.94 | +0.21 | +3.7% | $5.64 | $5.99 | $5.64 | 10,600 | |
| $5.73 | -0.157 | -2.7% | $5.86 | $5.916 | $5.73 | 4,800 | |
| $5.887 | -0.123 | -2.0% | $6.00 | $6.00 | $5.60 | 1,700 | |
| $6.01 | +0.118 | +2.0% | $5.91 | $6.01 | $5.745 | 19,700 | |
| $5.892 | -0.088 | -1.5% | $5.77 | $5.892 | $5.77 | 1,700 | |
| $5.98 | +0.457 | +8.3% | $5.63 | $5.98 | $5.61 | 5,100 | |
| $5.523 | +0.006 | +0.1% | $5.70 | $5.79 | $5.477 | 3,700 | |
| $5.517 | +0.077 | +1.4% | $5.57 | $5.80 | $5.50 | 7,200 | |
| $5.44 | -0.36 | -6.2% | $5.80 | $5.81 | $5.44 | 7,000 | |
| $5.80 | -0.14 | -2.4% | $5.74 | $6.05 | $5.739 | 8,600 | |
| $5.94 | +0.11 | +1.9% | $5.71 | $6.19 | $5.60 | 18,800 | |
| $5.83 | -0.17 | -2.8% | $5.965 | $6.05 | $5.83 | 8,000 | |
| $6.00 | +0.17 | +2.9% | $5.71 | $6.076 | $5.71 | 4,100 | |
| $5.83 | -0.032 | -0.5% | $6.07 | $6.19 | $5.70 | 21,400 | |
| $5.862 | +0.462 | +8.6% | $5.30 | $6.15 | $5.30 | 26,800 | |
| $5.40 | -0.12 | -2.2% | $5.51 | $5.81 | $5.40 | 3,700 | |
| $5.52 | +0.37 | +7.2% | $5.50 | $5.70 | $5.39 | 6,700 | |
| $5.15 | +0.14 | +2.8% | $5.00 | $5.40 | $4.90 | 4,600 | |
| $5.01 | -0.12 | -2.3% | $5.22 | $5.30 | $4.85 | 13,200 | |
| $5.13 | 0.00 | 0.0% | $5.13 | $5.13 | $5.13 | 2,900 | |
| $5.13 | -0.25 | -4.6% | $4.98 | $5.13 | $4.98 | 1,400 | |
| $5.38 | +0.145 | +2.8% | $5.25 | $5.38 | $5.19 | 2,000 | |
| $5.235 | -0.165 | -3.1% | $5.34 | $5.49 | $5.151 | 1,500 | |
| $5.40 | +0.04 | +0.7% | $5.34 | $5.50 | $5.20 | 2,700 | |
| $5.36 | -0.43 | -7.4% | $5.61 | $5.61 | $5.35 | 3,000 | |
| $5.79 | -0.027 | -0.5% | $5.75 | $5.81 | $5.56 | 7,400 | |
| $5.817 | +0.967 | +19.9% | $4.814 | $5.817 | $4.814 | 11,500 | |
| $4.85 | -0.15 | -3.0% | $4.85 | $4.85 | $4.80 | 3,200 |
- Ticker
- Frankfurt:BE50
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Sep 1, 2026
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
Latest deck · Jul 2, 2026
Investor Presentation (July 2026)
Investor deck · 12 slides
Latest news
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
Sep 1, 2026
Closed $5.89 (-1.5%) on Sep 1, 2026
CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference
Aug 27, 2026
Closed $5.52 (+1.4%) on Aug 27, 2026
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation
Aug 12, 2026
Closed $5.01 (-2.3%) on Aug 12, 2026
CNS Pharmaceuticals (NASDAQ: CNSP) Highlights Oversubscribed $22.5M Financing, Growth Strategy in Investor Presentation
Jun 9, 2026
Closed $4.59 (-6.1%) on Jun 9, 2026
CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment
Jun 8, 2026
Closed $4.89 (-2.2%) on Jun 8, 2026
CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress
May 20, 2026
Closed $5.10 (+6.7%) on May 20, 2026
CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress
May 14, 2026
Closed $5.01 (-9.2%) on May 14, 2026
CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing
May 4, 2026
Closed $7.84 (+239.2%) on May 4, 2026
CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline
Mar 11, 2026
Closed $2.96 (-11.6%) on Mar 11, 2026
CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team
Mar 2, 2026
Closed $3.13 (+0.6%) on Mar 2, 2026
Decks
Investor Presentation (July 2026)
Investor deck · 12 slides · Jul 2, 2026
Investor Presentation (March 2026)
Investor deck · 12 slides · March 2026
Investor Presentation (September 2025)
Investor deck · 20 slides · September 2025
Investor Presentation (July 2025)
Investor deck · 20 slides · Jul 15, 2025
CNS Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 171 in all · newest Sep 1, 2026 · oldest 2019
- Decks
- 24 decks · latest Jul 2, 2026
Where CNS Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CNSP · Home listing | NASDAQ | United States | USD |
| BOATS:CNSP | BOATS | United States | USD |
| Frankfurt:BE50 · This page | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about CNS Pharmaceuticals, Inc.